Тhe State Expert Center of the Health Ministry of Ukraine gave positive conclusions regarding conducting 248 clinical trials of medicines in 2019, which is 19.23% more than in 2018, the center has reported on its website. According to the report, 210 studies were conducted by foreign manufacturers as part of international multicenter clinical studies, and 38 – by domestic manufacturers.
According to the center, an analysis of clinical trials materials in recent years has shown that the most commonly used drugs are used to treat diseases in the field of oncology, psychiatry, neurology, gastroenterology, pulmonology, rheumatology, and other diseases.
Most clinical trials were carried out in Kyiv – 21%. Kharkiv – 13%, Vinnytsia – 10%, Dnipro – 7%, Zaporizhia – 6%, Ivano-Frankivsk – 6%, Lviv – 6%, and Odesa – 5%.
Ukraine can join India, Israel, and Thailand and become another major platform for the rapidly growing industry of clinical trials of new drugs, James Peyer, managing partner of the U.S. biotechnology company Apollo Ventures, has said. “Clinical trials can be carried out (in Ukraine) with the same level of professionalism, with the same level of effectiveness as in the United States and Europe but without their high costs,” he said at the Ukraine House Davos health panel.
As reported earlier, bill No. 4074 on ensuring public access to the results of preclinical study and clinical trials of medicines was passed into law by the Ukrainian parliament in September 2018.
At present, about 200 clinical drug trials are underway in Ukraine. At the same time, in the past two years, the trend toward a decrease in the number of clinical trials has subsided.
